BioPharmSignal logoBioPharmSignal

Biotech News

Progyny Expands Access to Fertility and Women’s Health with Industry’s First Fully Insured Supplemental Plan

Progyny (PGNY)ProgynyCompany update

First-of-its-kind plan expands access to comprehensive, outcomes-based family building and women’s health care with predictable costs for small U.S. employers NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions,

Related news

PGNYProgyny2025-11-20 14:23 EST

New Men’s Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action

PGNYProgyny2026-04-01 13:23 EST

Progyny Commemorates 10 Years of Redefining Women’s Health and Family Building Care

FEMYFEMASYS2026-05-13 13:00 EST

Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter

FEMYFEMASYS2026-05-05 13:00 EST

Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete

HSTMHealthStream2026-04-21 13:25 EST

HealthStream to Host First Quarter 2026 Earnings Conference Call

TDOCTeladoc2025-10-14 10:00 EST

Teladoc Health Adds Workplace Safety Capability to its AI-Enabled Clarity™ Monitoring Solution for Hospitals and Health Systems

MGRXMANGOCEUTICALS2025-03-25 13:00 EST

Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada

View all latest news

Progyny

Women's Health and Family Building Progyny manages employer-sponsored benefits for fertility, family building and women's health. Its programs are designed to guide members through complex care while helping benefit purchasers manage quality and cost. Integrated Benefit Platform The company's services include fertility treatment,...

Recent company news

PGNYProgyny2026-08-07 14:51 EST

Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference

PGNYProgyny2026-08-06 20:01 EST

Progyny, Inc. Announces Second Quarter 2026 Results

PGNYProgyny2026-07-23 19:30 EST

Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report

PGNYProgyny2026-05-28 13:04 EST

New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

PGNYProgyny2026-05-26 12:00 EST

Progyny, Inc. Announces Share Repurchase Program

Stock data

Close
30.21 USD
Market cap
1.97B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States